相似文献
1
Defensins in viral infections.
J Innate Immun. 2009;1(5):413-20. doi: 10.1159/000226256. Epub 2009 Jun 24.
2
Perspectives for clinical use of engineered human host defense antimicrobial peptides.
FEMS Microbiol Rev. 2017 May 1;41(3):323-342. doi: 10.1093/femsre/fux012.
3
Defensins: A Double-Edged Sword in Host Immunity.
Front Immunol. 2020 May 7;11:764. doi: 10.3389/fimmu.2020.00764. eCollection 2020.
4
Antimicrobial peptides alter early immune response to influenza A virus infection in C57BL/6 mice.
Antiviral Res. 2016 Sep;133:208-17. doi: 10.1016/j.antiviral.2016.08.013. Epub 2016 Aug 13.
5
Defensins in innate antiviral immunity.
Nat Rev Immunol. 2006 Jun;6(6):447-56. doi: 10.1038/nri1860.
6
Human Oral Defensins Antimicrobial Peptides: A Future Promising Antimicrobial Drug.
Curr Pharm Des. 2018;24(10):1130-1137. doi: 10.2174/1381612824666180403114615.
7
Defensins in Viral Infection and Pathogenesis.
Annu Rev Virol. 2017 Sep 29;4(1):369-391. doi: 10.1146/annurev-virology-101416-041734. Epub 2017 Jul 17.
8
Antiviral Activities of Human Host Defense Peptides.
Curr Med Chem. 2020;27(9):1420-1443. doi: 10.2174/0929867326666190805151654.
9
Defensin participation in innate and adaptive immunity.
Curr Pharm Des. 2007;13(30):3131-9. doi: 10.2174/138161207782110453.
10
Defensins and other antimicrobial peptides: a historical perspective and an update.
Comb Chem High Throughput Screen. 2005 May;8(3):209-17. doi: 10.2174/1386207053764594.
引用本文的文献
1
Development of a candidate mRNA vaccine based on Multi-Peptide targeting VP4 of rotavirus A: an immunoinformatics and molecular dynamics approach.
Sci Rep. 2025 Jul 2;15(1):22610. doi: 10.1038/s41598-025-07433-4.
2
In Vitro Profiling of the Antiviral Peptide TAT-I24.
Int J Mol Sci. 2024 Sep 28;25(19):10463. doi: 10.3390/ijms251910463.
3
Exploring computational approaches to design mRNA Vaccine against vaccinia and Mpox viruses.
Immun Inflamm Dis. 2024 Aug;12(8):e1360. doi: 10.1002/iid3.1360.
4
Etiology of viral induced acute liver failure and defensins as potential therapeutic agents in ALF treatment.
Front Immunol. 2023 Apr 21;14:1153528. doi: 10.3389/fimmu.2023.1153528. eCollection 2023.
5
The molecular basis of differential host responses to avian influenza viruses in avian species with differing susceptibility.
Front Cell Infect Microbiol. 2023 Feb 28;13:1067993. doi: 10.3389/fcimb.2023.1067993. eCollection 2023.
6
β-Defensin-1 Regulates Influenza Virus Infection in Human Bronchial Epithelial Cells through the STAT3 Signaling Pathway.
Pathogens. 2023 Jan 11;12(1):123. doi: 10.3390/pathogens12010123.
7
Association between Immunologic Markers and Cirrhosis in Individuals from a Prospective Chronic Hepatitis C Cohort.
Cancers (Basel). 2022 Oct 27;14(21):5280. doi: 10.3390/cancers14215280.
8
Screening of Herbal Medicinal Products for Their Supportive Curing Potential in the Context of SARS-CoV-2.
Evid Based Complement Alternat Med. 2022 Sep 6;2022:8038195. doi: 10.1155/2022/8038195. eCollection 2022.
9
Defensins: Therapeutic molecules with potential to treat SARS-CoV-2 infection.
Indian J Med Res. 2022 Jan;155(1):83-85. doi: 10.4103/ijmr.ijmr_2798_21.
10
Fusion-inhibition peptide broadly inhibits influenza virus and SARS-CoV-2, including Delta and Omicron variants.
Emerg Microbes Infect. 2022 Dec;11(1):926-937. doi: 10.1080/22221751.2022.2051753.
本文引用的文献
1
Role of beta-defensin-1 polymorphisms in mother-to-child transmission of HIV-1.
J Acquir Immune Defic Syndr. 2009 May 1;51(1):13-9. doi: 10.1097/QAI.0b013e31819df249.
2
Levels of innate immune factors in genital fluids: association of alpha defensins and LL-37 with genital infections and increased HIV acquisition.
AIDS. 2009 Jan 28;23(3):309-17. doi: 10.1097/QAD.0b013e328321809c.
3
Neutrophil-derived defensins as modulators of innate immune function.
Crit Rev Immunol. 2008;28(3):185-200. doi: 10.1615/critrevimmunol.v28.i3.10.
4
Increased levels of human beta-defensins mRNA in sexually HIV-1 exposed but uninfected individuals.
Curr HIV Res. 2008 Nov;6(6):531-8. doi: 10.2174/157016208786501463.
5
Human alpha-defensins inhibit BK virus infection by aggregating virions and blocking binding to host cells.
J Biol Chem. 2008 Nov 7;283(45):31125-32. doi: 10.1074/jbc.M805902200. Epub 2008 Sep 9.
6
Enhanced expression of murine beta-defensins (MBD-1, -2,- 3, and -4) in upper and lower airway mucosa of influenza virus infected mice.
Virology. 2008 Oct 10;380(1):136-43. doi: 10.1016/j.virol.2008.07.024. Epub 2008 Aug 27.
7
Human defensins and cytokines in vaginal lavage fluid of women with bacterial vaginosis.
Int J Gynaecol Obstet. 2008 Oct;103(1):50-4. doi: 10.1016/j.ijgo.2008.05.020. Epub 2008 Jul 16.
8
Single-nucleotide polymorphisms in human beta-defensin-1 gene in Mozambican HIV-1-infected women and correlation with virologic parameters.
AIDS. 2008 Jul 31;22(12):1515-7. doi: 10.1097/QAD.0b013e3282fd6e0c.
9
Role of human beta-defensin-2 during tumor necrosis factor-alpha/NF-kappaB-mediated innate antiviral response against human respiratory syncytial virus.
J Biol Chem. 2008 Aug 15;283(33):22417-29. doi: 10.1074/jbc.M710415200. Epub 2008 Jun 20.
10
Neisseria gonorrhoeae-induced human defensins 5 and 6 increase HIV infectivity: role in enhanced transmission.
J Immunol. 2008 May 1;180(9):6176-85. doi: 10.4049/jimmunol.180.9.6176.
Zotero 插件